Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Contraceptive risk: the FDA, Depo-Provera, and the politics of experimental medicine: by William Green, New York, NY: New York University Press, 2017, 336 pp., ISBN 9781479836987New genetics and society, 2019-10, Vol.38 (4), p.455-457 [Peer Reviewed Journal]ISSN: 1463-6778 ;EISSN: 1469-9915 ;DOI: 10.1080/14636778.2019.1601010Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
The Current Status of Gene Therapy for the Treatment of CancerBiologics, 2021-01, Vol.15, p.67-77 [Peer Reviewed Journal]2021 Belete. ;COPYRIGHT 2021 Dove Medical Press Limited ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Belete. 2021 Belete. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S302095 ;PMID: 33776419Full text available |
|
3 |
Material Type: Article
|
Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committeeAmyloid, 2018-10, Vol.25 (4), p.215-219 [Peer Reviewed Journal]2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2019 ;ISSN: 1350-6129 ;ISSN: 1744-2818 ;EISSN: 1744-2818 ;DOI: 10.1080/13506129.2018.1549825Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
Progressive fibrosing interstitial lung diseases: current practice in diagnosis and managementCurrent medical research and opinion, 2019-11, Vol.35 (11), p.2015-2024 [Peer Reviewed Journal]2019 Boehringer Ingelheim. Published by Informa UK Limited, trading as Taylor & Francis Group. 2019 ;ISSN: 0300-7995 ;EISSN: 1473-4877 ;DOI: 10.1080/03007995.2019.1647040Digital Resources/Online E-Resources |
|
5 |
Material Type: Article
|
Antibodies to watch in 2019mAbs, 2019-02, Vol.11 (2), p.219-238 [Peer Reviewed Journal]2018 The Author(s). Published with license by Taylor & Francis Group, LLC 2018 ;2018 The Author(s). Published with license by Taylor & Francis Group, LLC 2018 The Author(s) ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2018.1556465 ;PMID: 30516432Full text available |
|
6 |
Material Type: Article
|
Advances with Platelet-Rich Plasma for Bone HealingBiologics, 2024-01, Vol.18, p.29-59 [Peer Reviewed Journal]2024 Bacevich et al. ;COPYRIGHT 2024 Dove Medical Press Limited ;2024 Bacevich et al. 2024 Bacevich et al. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S290341 ;PMID: 38299120Full text available |
|
7 |
Material Type: Article
|
Ultrasensitive circulating tumor DNA analysis enables precision medicine: experimental workflow considerationsExpert review of molecular diagnostics, 2021-03, Vol.21 (3), p.299-310 [Peer Reviewed Journal]2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 ;ISSN: 1473-7159 ;EISSN: 1744-8352 ;DOI: 10.1080/14737159.2021.1889371Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Stem Cell Therapy for Retinal Degeneration: The Evidence to DateBiologics, 2021-01, Vol.15, p.299-306 [Peer Reviewed Journal]COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Sharma and Jaganathan. 2021 Sharma and Jaganathan. ;ISSN: 1177-5491 ;ISSN: 1177-5475 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S290331 ;PMID: 34349498Full text available |
|
9 |
Material Type: Article
|
Publication bias: what is it? How do we measure it? How do we avoid it?Open Access Journal of Clinical Trials, 2013-01, Vol.5 (default), p.71-81 [Peer Reviewed Journal]COPYRIGHT 2013 Dove Medical Press Limited ;COPYRIGHT 2013 Dove Medical Press Limited ;2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1179-1519 ;EISSN: 1179-1519 ;DOI: 10.2147/OAJCT.S34419Full text available |
|
10 |
Material Type: Article
|
Structure, heterogeneity and developability assessment of therapeutic antibodiesmAbs, 2019-02, Vol.11 (2), p.239-264 [Peer Reviewed Journal]2018 Taylor & Francis Group, LLC 2018 ;2018 Taylor & Francis Group, LLC 2018 Taylor & Francis ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2018.1553476 ;PMID: 30543482Full text available |
|
11 |
Material Type: Article
|
Antibodies to watch in 2023mAbs, 2023-12, Vol.15 (1), p.2153410-2153410 [Peer Reviewed Journal]2022 The Author(s). Published with license by Taylor & Francis Group, LLC. 2022 ;2022 The Author(s). Published with license by Taylor & Francis Group, LLC. 2022 The Author(s) ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2022.2153410 ;PMID: 36472472Full text available |
|
12 |
Material Type: Article
|
Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a reviewCurrent medical research and opinion, 2022-08, Vol.38 (8), p.1391-1399 [Peer Reviewed Journal]2022 Johnson & Johnson, LLC. Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;ISSN: 0300-7995 ;EISSN: 1473-4877 ;DOI: 10.1080/03007995.2022.2081454Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
The making of bispecific antibodiesmAbs, 2017-02, Vol.9 (2), p.182-212 [Peer Reviewed Journal]2017 The Author(s). Published with license by Taylor & Francis Group, LLC © Ulrich Brinkmann and Roland E. Kontermann 2017 ;2017 The Author(s). Published with license by Taylor & Francis Group, LLC 2017 The Author(s) ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2016.1268307 ;PMID: 28071970Full text available |
|
14 |
Material Type: Article
|
The "less-is-more" in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicitymAbs, 2018-07, Vol.10 (5), p.693-711 [Peer Reviewed Journal]2018 The Author(s). Published with license by Taylor & Francis Group, LLC © Natasha A. Pereira, Kah Fai Chan, Pao Chun Lin, and Zhiwei Song 2018 ;2018 The Author(s). Published with license by Taylor & Francis Group, LLC 2018 The Author(s) ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2018.1466767 ;PMID: 29733746Full text available |
|
15 |
Material Type: Article
|
Antibodies to watch in 2020mAbs, 2020-01, Vol.12 (1), p.1703531-1703531 [Peer Reviewed Journal]2019 The Author(s). Published with license by Taylor & Francis Group, LLC. 2019 ;2019 The Author(s). Published with license by Taylor & Francis Group, LLC. 2019 The Author(s) ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2019.1703531 ;PMID: 31847708Full text available |
|
16 |
Material Type: Article
|
Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committeeAmyloid, 2020-10, Vol.27 (4), p.217-222 [Peer Reviewed Journal]2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;ISSN: 1350-6129 ;ISSN: 1744-2818 ;EISSN: 1744-2818 ;DOI: 10.1080/13506129.2020.1835263Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
Treatment Persistence of Apremilast Among Patients with Psoriatic ArthritisBiologics, 2023-01, Vol.17, p.129-136 [Peer Reviewed Journal]COPYRIGHT 2023 Dove Medical Press Limited ;2023 Haddad et al. 2023 Haddad et al. ;ISSN: 1177-5491 ;ISSN: 1177-5475 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S425693Full text available |
|
18 |
Material Type: Article
|
Toll-like receptors and COVID-19: a two-faced story with an exciting endingFuture science OA, 2020-09, Vol.6 (8), p.FSO605 [Peer Reviewed Journal]2020 Carlo Buonerba ;2020 Carlo Buonerba 2020 ;ISSN: 2056-5623 ;EISSN: 2056-5623 ;DOI: 10.2144/fsoa-2020-0091 ;PMID: 32974046Full text available |
|
19 |
Material Type: Article
|
The therapeutic monoclonal antibody marketmAbs, 2015-01, Vol.7 (1), p.9-14 [Peer Reviewed Journal]2015 BioProcess Technology Consultants, Inc. 2015 ;2015 BioProcess Technology Consultants, Inc. 2015 BioProcess Technology Consultants, Inc. ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.4161/19420862.2015.989042 ;PMID: 25529996Full text available |
|
20 |
Material Type: Article
|
Antibodies to watch in 2018mAbs, 2018-02, Vol.10 (2), p.183-203 [Peer Reviewed Journal]2018 The Author(s). Published with license by Taylor & Francis Group, LLC © Hélène Kaplon and Janice M. Reichert 2018 ;2018 The Author(s). Published with license by Taylor & Francis Group, LLC 2018 The Author(s) ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2018.1415671 ;PMID: 29300693Full text available |